Stock listing

IMDX Stock Price, News, Filings & Events — Insight Molecular Diagnostics Inc.

Selected listing: IMDX · BOATS · USD · US

This page tracks Insight Molecular Diagnostics Inc.'s IMDX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMDX:BOATS. IMDX:BOATS is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, specializing in molecular diagnostics. With a market capitalization of approximately $153 million, the company focuses on developing innovative diagnostic solutions. Their advancements aim to improve patient outcomes through precise and timely medical testing.

IMDX:BOATSUSDUSUpdated August 1, 2026
Insight Molecular Diagnostics Inc. logo
Ticker
IMDX:BOATS
Asset type
Stock
Market cap
$150.1M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Insight Molecular Diagnostics Inc. IMDX:BOATS stock context

This page tracks Insight Molecular Diagnostics Inc.'s IMDX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMDX:BOATS. IMDX:BOATS is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, specializing in molecular diagnostics. With a market capitalization of approximately $153 million, the company focuses on developing innovative diagnostic solutions. Their advancements aim to improve patient outcomes through precise and timely medical testing.

Research Insight Molecular Diagnostics Inc.

Alternate listings